Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (AVHHL) Shares Outstanding (Weighted Average) (2018 - 2025)

Historic Shares Outstanding (Weighted Average) for AVITA Medical (AVHHL) over the last 8 years, with Q3 2025 value amounting to $28.4 million.

  • AVITA Medical's Shares Outstanding (Weighted Average) rose 927.28% to $28.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.4 million, marking a year-over-year increase of 927.28%. This contributed to the annual value of $25.3 million for FY2023, which is 132.43% up from last year.
  • According to the latest figures from Q3 2025, AVITA Medical's Shares Outstanding (Weighted Average) is $28.4 million, which was up 927.28% from $26.4 million recorded in Q2 2025.
  • In the past 5 years, AVITA Medical's Shares Outstanding (Weighted Average) ranged from a high of $28.4 million in Q3 2025 and a low of $22.7 million during Q2 2021
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $25.2 million (2023), whereas its average is $25.3 million.
  • As far as peak fluctuations go, AVITA Medical's Shares Outstanding (Weighted Average) skyrocketed by 1581.75% in 2021, and later skyrocketed by 34.02% in 2022.
  • Over the past 5 years, AVITA Medical's Shares Outstanding (Weighted Average) (Quarter) stood at $24.9 million in 2021, then increased by 0.34% to $25.0 million in 2022, then grew by 1.32% to $25.3 million in 2023, then increased by 2.58% to $26.0 million in 2024, then grew by 9.27% to $28.4 million in 2025.
  • Its last three reported values are $28.4 million in Q3 2025, $26.4 million for Q2 2025, and $26.3 million during Q1 2025.